NeoStrata’s Novel Coal Tar Product Scores Well For Psoriasis, Convenience
This article was originally published in The Tan Sheet
Executive Summary
A novel OTC leave-on topical solution achieved significantly greater and more persistent improvement compared to prescription calcipotriol cream in patients with moderate chronic plaque psoriasis in a randomized trial
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning